1. Repository of Kharkiv National Medical University

Browsing by Author Kniazkova, I.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

А Б В Г Ґ Д Е Є Ё Ж З И І Ї Й К Л М Н О П Р С Т У Ф Х Ц Ч Ш Щ Ъ Ы Ь Э Ю Я
or enter first few letters:  
Showing results 1 to 9 of 9
PreviewIssue DateTitleAuthor(s)
2023Dynamics of SST2 and NT-PROBNP in patients with arterial hypertension and type 2 diabetes mellitus based on combined therapy with eplerenone and trimetazidine additionBilovol, O.; Kniazkova, I.; Kirienko, O.; Kuzminova, N.; Sushetska, A.; Starenkiy, V.; Abramova, L.
2022Dysautonomia involvement in maternal cardiac arrhythmiaLakhno, Olha; Lakhno, K.; Kniazkova, I.; Uzel, K.
2023Effect of anti-hypertensive therapy on arterial wall stiffness in patients with arterial hypertensionBilovol, O.; Kniazkova, I.; Mishchenko, V.; Zhadan, A.; Kuzminova, N.; Starenky, A.; Bogun, M.
2022Functional condition of kidneys in patients with arterial hypertension in combination with type 2 diabetes mellitusBilovol, O.; Kniazkova, I.; Kirienko, O.; Kuzminova, N.; Golovachova, V.; Kirienko, D.; Abramova, L.
Bilovol et al_Hepatic fibrosis as an additional.pdf.jpg2021Hepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver diseaseBilovol, O.; Kniazkova, I.; Zemlianitsyna, O.; Dunaieva, I.; Romanova, I.; Kurilo, O.; Sinaiko, V.; Kravchun, N.
Статья Синайко WoS 2021.pdf.jpg2021Hepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver diseaseBilovol, O.; Kniazkova, I.; Zemlianitsyna, O.; Dunaieva, I.; Romanova, I.; Kurilo, O.; Sinaiko, V.; Kravchun, N.
2023Influence of ethylmethylhydroxypyridine succinate inclusion in antihypertensive therapy on the condition of the arterial wall in young patients with hypertensionBilovol, O.; Kniazkova, I.; Mishchenko, V.; Kuzminova, N.; Starenkyi, V.; Zhadan, A.; Bogun, M.
2023Markers of endothelial dysfunction as criteria for destabilization of the disease course in patients with coronary artery diseaseRomanova, V.; Kuzminova, N.; Romanova, L.; Lozynskyi, S.; Kniazkova, I.; Kulchytska, O.; Shkarovskyi, Y.
Bilovol et al._Therapeutic efficacy.pdf.jpg2021Терапевтична ефективність кверцетину у пацієнтів з артеріальною гіпертензією та метаболічним синдромомBilovol, O.; Kniazkova, I.; Kuzminova, Natalia; Kirienko, O.; Abramova, L.; Gavrylyuk, A.
Showing results 1 to 9 of 9